White House releases statement on at-home COVID-19 testing, potential cost implications - Bim Group

White House releases statement on at-home COVID-19 testing, potential cost implications

SOURCE: UnitedHealthcare

READ TIME: 2 MINUTES

On Dec. 2, 2021, the White House released a statement announcing several actions to fight COVID-19, including requiring commercial health plans to cover COVID-19 at-home tests – approved or authorized by the Food and Drug Administration (FDA) – without cost-sharing. The White House has directed the Tri-Agencies (Departments of Health and Human Services, Labor and the Treasury) to issue guidance implementing this policy by Jan. 15, 2022.

The following information has been conveyed through the statement and press announcement:

  • The requirements will likely apply to fully insured, level-funded and self-funded group plans, including grandfathered and transitional relief business and business through the Exchanges.
  • The Administration preliminarily indicated the coverage requirements would not apply retroactively and would only provide coverage for diagnostic tests, as the current requirement stipulates.
  • Any requirements would likely extend through the Public Health Emergency.

UnitedHealthcare regulatory, clinical, actuarial, operations and COVID-19 testing teams are working to address and respond to the guidance when it is released.

The guidance is expected to impact 2022 health care spending. For example, at an average cost of $25 for 2 tests, and 6 tests submitted per member in 2022, the additional cost per member would be $75.

UnitedHealthcare will provide input to the Administration on how to best implement this new policy in a manner that balances access with affordability and patient safety.

Please contact your broker or UnitedHealthcare representative if you have questions or would like to learn more about advocacy efforts.

Recent Insights

May 20, 2024
Webinar

Webinar: Mastering COBRA Every Day and in M&A

Tuesday, June 11, 2024 1 – 2PM CST Register Now Registration Code:UBA410EW   Attend this month’s webinar to learn how to administer COBRA effectively. Gain insights into: The determining factors for employer and employee COBRA eligibility The interaction between COBRA and leaves of absence Health plans and tax-favored accounts that can be used with COBRA […]
Read more
May 20, 2024
News

HHS Finalizes Section 1557 Nondiscrimination Regulations under the Affordable Care Act

READ TIME: 7 MINUTES The Office of Civil Rights (OCR) at the U.S. Department of Health and Human Services (HHS) together with the Centers for Medicare and Medicaid Services (CMS) released regulations under Section 1557 of the Affordable Care Act (the “Final Rule”) on April 26, 2024. These final regulations follow almost two years after […]
Read more
May 20, 2024
News

IRS Releases 2025 Limits for HDHPs and HSAs

READ TIME: 4 MINUTES The IRS recently issued Revenue Procedure 2024-25 to announce the 2025 inflation-adjusted amounts that apply to health savings accounts (HSAs), excepted benefit health reimbursement arrangements (EBHRAs), and high-deductible health plans (HDHPs). The newly announced figures result in increases in the applicable limits for 2025, including the maximum contribution limit for an […]
Read more
May 20, 2024
News

FAQs about the Patient Centered Outcomes Research Institute (PCORI) Fee

READ TIME: 10 MINUTES The Patient-Centered Outcomes Research Institute (PCORI) fee initially applied from 2012 to 2019. However, in December 2019, the Further Consolidated Appropriations Act, 2020 extended the fee to 2029. The PCORI fee applies to all plans that provide medical coverage to employees. Medical coverage includes preferred provider (PPO) plans, health maintenance organization […]
Read more